Bieber, Thomas

Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, Fc ε RI

Jürgens, M., Wollenberg, A., Hanau, D., de la Salle, H., & Bieber, T. (1995) · The Journal of Immunology

Dermatology and Skin DiseasesMast cells and histamine

Cited by 146

Atopic dermatitis: a candidate for disease‐modifying strategy

Bieber, T., Cork, M., & Reitamo, S. (2012) · Allergy

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 131

The role of environmental factors in allergy: A critical reappraisal

Gilles, S., Akdis, C., Lauener, R., Schmid‐Grendelmeier, P., Bieber, T., Schäppi, G., & Traidl‐Hoffmann, C. (2018) · Experimental Dermatology

Allergic Rhinitis and SensitizationAsthma and respiratory diseases

Cited by 97

Skin homing of Langerhans cell precursors: Adhesion, chemotaxis, and migration

Koch, S., Kohl, K., Klein, E., von Bubnoff, D., & Bieber, T. (2006) · Journal of Allergy and Clinical Immunology

Immunotherapy and Immune ResponsesChemokine receptors and signaling

Cited by 65

Langerhans and inflammatory dendritic epidermal cells in atopic dermatitis are tolerized toward TLR 2 activation

Iwamoto, K., Nümm, T. J., Koch, S., Herrmann, N., Leib, N., & Bieber, T. (2018) · Allergy

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 61

Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

Beck, L. A., Bieber, T., Weidinger, S., Tauber, M., Saeki, H., Irvine, A. D., Eichenfield, L. F., Werfel, T., Arlert, P., Jiang, L., et al. (2023) · Journal of the American Academy of Dermatology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 56

Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREAT germany

Abraham, S., Haufe, E., Harder, I., Heratizadeh, A., Kleinheinz, A., Wollenberg, A., Weisshaar, E., Augustin, M., Wiemers, F., Zink, A., et al. (2020) · British Journal of Dermatology

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 53

Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis

Bernardo, D., Bieber, T., & Torres, T. (2023) · American Journal of Clinical Dermatology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 43

JAK1/2 inhibition impairs the development and function of inflammatory dendritic epidermal cells in atopic dermatitis

Klaeschen, A. S., Nümm, T. J., Herrmann, N., Leib, N., Maintz, L., Sakai, T., Wenzel, J., & Bieber, T. (2021) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 36

Serum sphingosine‐1‐phosphate is elevated in atopic dermatitis and associated with severity

Sakai, T., Herrmann, N., Maintz, L., Nümm, T. J., Welchowski, T., Claus, R. A., Gräler, M. H., & Bieber, T. (2021) · Allergy

Dermatology and Skin DiseasesSphingolipid Metabolism and Signaling

Cited by 25